Correction: Future antimalarials from Artemisia? A rationale for natural product mining against drug-refractory Plasmodium stages

IF 12.7 1区化学 Q1 CHEMISTRY, MULTIDISCIPLINARY

ACS Central Science Pub Date : 2024-01-01 DOI:10.1039/d4np90001d

Alexandre Maciuk , Dominique Mazier , Romain Duval

引用次数: 0

Abstract

Correction for ‘Future antimalarials from Artemisia? A rationale for natural product mining against drug-refractory Plasmodium stages’ by Alexandre Maciuk et al., Nat. Prod. Rep., 2023, 40, 1130–1144, https://doi.org/10.1039/D3NP00001J.

查看原文本刊更多论文

更正：未来的青蒿抗疟药？针对难治性疟原虫阶段挖掘天然产品的理由。

对 Alexandre Maciuk 等人在 Nat.Nat.杂志上发表的 "来自青蒿的未来抗疟药？针对难治性疟原虫阶段的天然产品开采原理 "的更正，作者 Alexandre Maciuk 等人，Nat.Rep.Rep., 2023, 40, 1130-1144, https://doi.org/10.1039/D3NP00001J。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

ACS Central Science Chemical Engineering-General Chemical Engineering

CiteScore

25.50

自引率

0.50%

发文量

194

审稿时长

10 weeks

期刊介绍： ACS Central Science publishes significant primary reports on research in chemistry and allied fields where chemical approaches are pivotal. As the first fully open-access journal by the American Chemical Society, it covers compelling and important contributions to the broad chemistry and scientific community. "Central science," a term popularized nearly 40 years ago, emphasizes chemistry's central role in connecting physical and life sciences, and fundamental sciences with applied disciplines like medicine and engineering. The journal focuses on exceptional quality articles, addressing advances in fundamental chemistry and interdisciplinary research.